344 related articles for article (PubMed ID: 27442231)
1. Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Islam MK; Jackson PJ; Rahman KM; Thurston DE
Future Med Chem; 2016 Jul; 8(11):1259-90. PubMed ID: 27442231
[TBL] [Abstract][Full Text] [Related]
2. A Personal History of Quadruplex-Small Molecule Targeting.
Neidle S
Chem Rec; 2015 Aug; 15(4):691-710. PubMed ID: 26096791
[TBL] [Abstract][Full Text] [Related]
3. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
4. Myricetin arrests human telomeric G-quadruplex structure: a new mechanistic approach as an anticancer agent.
Mondal S; Jana J; Sengupta P; Jana S; Chatterjee S
Mol Biosyst; 2016 Jul; 12(8):2506-18. PubMed ID: 27249025
[TBL] [Abstract][Full Text] [Related]
5. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution.
Ambrus A; Chen D; Dai J; Bialis T; Jones RA; Yang D
Nucleic Acids Res; 2006; 34(9):2723-35. PubMed ID: 16714449
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
7. Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer.
Neidle S
FEBS J; 2010 Mar; 277(5):1118-25. PubMed ID: 19951354
[TBL] [Abstract][Full Text] [Related]
8. Binding of anticancer drug adriamycin to parallel G-quadruplex DNA [d-(TTAGGGT)]
Raje S; Pandav K; Barthwal R
J Mol Recognit; 2020 Feb; 33(2):e2815. PubMed ID: 31793724
[TBL] [Abstract][Full Text] [Related]
9. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes.
Castor KJ; Mancini J; Fakhoury J; Weill N; Kieltyka R; Englebienne P; Avakyan N; Mittermaier A; Autexier C; Moitessier N; Sleiman HF
ChemMedChem; 2012 Jan; 7(1):85-94. PubMed ID: 22052801
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis of 4,5-diazafluorene derivatives and their anticancer activity via targeting telomeric DNA G-quadruplex.
Zhou K; Liu J; Xiong X; Cheng M; Hu X; Narva S; Zhao X; Wu Y; Zhang W
Eur J Med Chem; 2019 Sep; 178():484-499. PubMed ID: 31202994
[TBL] [Abstract][Full Text] [Related]
11. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response.
Che T; Chen SB; Tu JL; Wang B; Wang YQ; Zhang Y; Wang J; Wang ZQ; Zhang ZP; Ou TM; Zhao Y; Tan JH; Huang ZS
J Med Chem; 2018 Apr; 61(8):3436-3453. PubMed ID: 29618208
[TBL] [Abstract][Full Text] [Related]
13. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of human telomeric quadruplex structures.
Dai J; Carver M; Yang D
Biochimie; 2008 Aug; 90(8):1172-83. PubMed ID: 18373984
[TBL] [Abstract][Full Text] [Related]
15. Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules.
Pagano B; Amato J; Iaccarino N; Cingolani C; Zizza P; Biroccio A; Novellino E; Randazzo A
ChemMedChem; 2015 Apr; 10(4):640-9. PubMed ID: 25694275
[TBL] [Abstract][Full Text] [Related]
16. Quadruplex Nucleic Acids as Novel Therapeutic Targets.
Neidle S
J Med Chem; 2016 Jul; 59(13):5987-6011. PubMed ID: 26840940
[TBL] [Abstract][Full Text] [Related]
17. Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence.
Dai J; Carver M; Punchihewa C; Jones RA; Yang D
Nucleic Acids Res; 2007; 35(15):4927-40. PubMed ID: 17626043
[TBL] [Abstract][Full Text] [Related]
18. Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening.
Garavís M; López-Méndez B; Somoza A; Oyarzabal J; Dalvit C; Villasante A; Campos-Olivas R; González C
ACS Chem Biol; 2014 Jul; 9(7):1559-66. PubMed ID: 24837572
[TBL] [Abstract][Full Text] [Related]
19. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
20. Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence.
Di Leva FS; Zizza P; Cingolani C; D'Angelo C; Pagano B; Amato J; Salvati E; Sissi C; Pinato O; Marinelli L; Cavalli A; Cosconati S; Novellino E; Randazzo A; Biroccio A
J Med Chem; 2013 Dec; 56(23):9646-54. PubMed ID: 24256368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
